BioSpace News Archive

Bausch Health Companies Inc. will release its second-quarter 2019 financial results on Tuesday, Aug. 6, 2019.

Industry veteran brings extensive experience leading business development groups

Promotion of Dirk Brockstedt, Ph.D., to chief scientific officer and David Wustrow, Ph.D., to senior vice president, drug discovery and preclinical development.

NTT Research will Focus on Quantum Computing, Encryption and Precision Medicine; Grand Opening Ceremony, July 8, Rosewood Sand Hill

Through the partnership, Varian made available a TrueBeam™ system to the IAEA’s Dosimetry Laboratory in Seibersdorf, Austria, which will enhance the laboratory’s capacity to provide support in the areas of calibration and audit dosimetry services and relevant training.

SMPT Token will commence trading on IDAX on or around July 10, 2019, and shortly thereafter on LAToken.

The company’s management will host a conference call at 4:30 p.m. ET that same day to review the results.

Ligand Pharmaceuticals Incorporated and SQ Innovation AG announced that the two companies have entered into long-term, exclusive commercial license and supply agreements for use of Ligand’s Captisol® technology in the formulation of high-concentration furosemide for the treatment of edema in patients with heart failure.

OneOncology and AmerisourceBergen to Support Community Oncology Practices to Provide High-Quality Cancer Care to Patients Across the Nation

EINSTEIN-Jr is the largest pediatric trial conducted for the treatment of venous thromboembolism (VTE) and the first to evaluate a direct oral anticoagulant in this population